overige gezondheids parameters intestinal discomfort and general health
Conditions
Interventions
Subjects will daily consume a lunch meal containing approximately 11g of
Fermotein or control for 18 days.
Sponsors
Bioscienz
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Apparently healthy men and women Age between 18 and 70 years Body mass index (BMI) between 18.5 and 29.9 kg/m2
Exclusion criteria
Exclusion criteria: * Any metabolic, gastrointestinal, inflammatory or chronic disease (such as diabetes, anaemia, hepatitis, cardiovascular disease) * History of gastro-intestinal surgery or having (serious) gastro-intestinal complaints * History of liver dysfunction (cirrhosis, hepatitis) * Kidney dysfunction (self-reported) * Use of medication that may influence the study results, such as gastric acid inhibitors or laxatives * Reported slimming or medically prescribed diet * Current smokers * Alcohol intake *4 glasses of alcoholic beverages per day * Pregnant, lactating or wishing to become pregnant in the period of the study (self-reported) * Abuse of illicit drugs * Having food allergies * Participation in another clinical trial at the same time * Being an employee of the department Consumer Science & Health group of Wageningen Food & Biobased Research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primairy study parameter is frequency and severity of gastro-intestinal complaints. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are health parameters derived from blood samples taken before and after the intervention.Additional samples (including stool samples) will be collected to enable future measurements when requested by the assessment committee of the novel food dossier | — |
Countries
Netherlands
Outcome results
None listed